Speakers of the symposium
SESSION 1: Autoimmunity
Riitta Lahesmaa, Turku Centre for Biotechnology, Finland
"Molecular mechanisms of human lymphocyte differentiation to functionally distinct subsets"
Baidong Hou, Chinese Academy of Science, China
"Roles of Toll-like receptor signaling in antibody responses - implication in autoimmune diseases"
Adrian Hayday, King's College School of Medicine, UK
"How T cells work in the Tissues"
Thomas Hünig, University of Würzburg, Germany
"Reverse Translation: Lessons from the CD28 Superagonist TGN1412"
SESSION 2: Immunity of The Nervous System
Barry McColl, University of Edinburgh, UK
"Immunological mechanisms influencing stroke aetiology, pathology and recovery"
Li Tian, University of Helsinki, Finland
"Neuroimmune modulation of cell adhesion molecules in immune diseases"
Hartmut Wekerle, Max Planck Institute of Neurobiology, Germany
"Remote Control: Triggering of brain autoimmunity in gut and draining lymph nodes"
SESSION 3: Inflammation and Cancer
Nicolas Boisgerault, Mayo Clinic, USA
“Beyond direct oncolysis: Vesicular Stomatitis Virus expressing cDNA libraries for cancer therapy andidentification of relevant tumor antigens”
Benoît Van den Eynde, Ludwig Institute for Cancer Research, de Duve Institute, Université catholique deLouvain, Brussels, Belgium
"Boosting cancer immunotherapy by blocking tryptophan degradation"
Karin de Visser, The Netherlands Cancer Institute, The Netherlands
"Impact of the inflammatory tumor-microenvironment on metastatic breast cancer and chemotherapy efficacy"
Steven M. Albeda, University of Pennsylvania, USA
"Role of Tumor-Associated Neutrophils in Cancer"
STUDENT TALKS
13:30 - 13:50 Monica Golumbeanu, Aalto University, Espoo, Finland
"Studying bacteria through Next Generation Sequencing"
13:50 - 14:10 Iivo Hetemäki, Haartman Institute, University of Helsinki, Finland
"Increased antibody levels against gut commensals are associated with regulatory T cell defect in patientswith APECED"
SESSION 4: Immunotherapy
Vincenzo Bronte, University of Padua, Italy
"Overcoming physical barriers to cancer immunotherapy"
André M. Lieber, Washington University, USA
"Overcoming physical barriers to cancer immunotherapy"
Angus Dalgleish, University of London, UK
"Immunotherapy and Cancer"
SESSION 1: Autoimmunity
Riitta Lahesmaa, Turku Centre for Biotechnology, Finland
"Molecular mechanisms of human lymphocyte differentiation to functionally distinct subsets"
Baidong Hou, Chinese Academy of Science, China
"Roles of Toll-like receptor signaling in antibody responses - implication in autoimmune diseases"
Adrian Hayday, King's College School of Medicine, UK
"How T cells work in the Tissues"
Thomas Hünig, University of Würzburg, Germany
"Reverse Translation: Lessons from the CD28 Superagonist TGN1412"
SESSION 2: Immunity of The Nervous System
Barry McColl, University of Edinburgh, UK
"Immunological mechanisms influencing stroke aetiology, pathology and recovery"
Li Tian, University of Helsinki, Finland
"Neuroimmune modulation of cell adhesion molecules in immune diseases"
Hartmut Wekerle, Max Planck Institute of Neurobiology, Germany
"Remote Control: Triggering of brain autoimmunity in gut and draining lymph nodes"
SESSION 3: Inflammation and Cancer
Nicolas Boisgerault, Mayo Clinic, USA
“Beyond direct oncolysis: Vesicular Stomatitis Virus expressing cDNA libraries for cancer therapy andidentification of relevant tumor antigens”
Benoît Van den Eynde, Ludwig Institute for Cancer Research, de Duve Institute, Université catholique deLouvain, Brussels, Belgium
"Boosting cancer immunotherapy by blocking tryptophan degradation"
Karin de Visser, The Netherlands Cancer Institute, The Netherlands
"Impact of the inflammatory tumor-microenvironment on metastatic breast cancer and chemotherapy efficacy"
Steven M. Albeda, University of Pennsylvania, USA
"Role of Tumor-Associated Neutrophils in Cancer"
STUDENT TALKS
13:30 - 13:50 Monica Golumbeanu, Aalto University, Espoo, Finland
"Studying bacteria through Next Generation Sequencing"
13:50 - 14:10 Iivo Hetemäki, Haartman Institute, University of Helsinki, Finland
"Increased antibody levels against gut commensals are associated with regulatory T cell defect in patientswith APECED"
SESSION 4: Immunotherapy
Vincenzo Bronte, University of Padua, Italy
"Overcoming physical barriers to cancer immunotherapy"
André M. Lieber, Washington University, USA
"Overcoming physical barriers to cancer immunotherapy"
Angus Dalgleish, University of London, UK
"Immunotherapy and Cancer"